If you liked this article you might like

Bluebird, Kite and Juno Delivering CAR-T Cancer Study Updates to ASCO '17 Meeting
Insiders Are Loading Up on Kite Pharma, Cliffs Natural Resources and More
Former Dendreon CEO Mitch Gold Returns to Public Biotech Stage with Cancer Immunotherapy Merger